Dawn Zhu

AMG 9810 [(E)-3-(4-t-Butylphenyl)-N-(2,3-dihydrobenzo[b][1,4] dioxin-6-yl)acrylamide], a Novel Vanilloid Receptor 1 (TRPV1) Antagonist with Antihyperalgesic Properties

Narender R. Gavva, Rami Tamir, Yusheng Qu et al. · Journal of Pharmacology and Experimental Therapeutics · 2005 · 385 citations

The Vanilloid Receptor TRPV1 Is Tonically Activated <i>In Vivo</i> and Involved in Body Temperature Regulation

Narender R. Gavva, Anthony W. Bannon, Sekhar Surapaneni et al. · Journal of Neuroscience · 2007 · 308 citations · Full text

Pharmacologic Characterization of AMG 334, a Potent and Selective Human Monoclonal Antibody against the Calcitonin Gene-Related Peptide Receptor

Sonya G. Lehto, Dawn Zhu, Brian P. Smith et al. · Journal of Pharmacology and Experimental Therapeutics · 2015 · 207 citations

Repeated Administration of Vanilloid Receptor TRPV1 Antagonists Attenuates Hyperthermia Elicited by TRPV1 Blockade

Narender R. Gavva, Anthony W. Bannon, David N. Hovland et al. · Journal of Pharmacology and Experimental Therapeutics · 2007 · 170 citations

Antihyperalgesic Effects of (R,E)-N-(2-Hydroxy-2,3-dihydro-1 H-inden-4-yl)-3-(2-(piperidin-1-yl)-4-(trifluoromethyl)phenyl)-acrylamide (AMG8562), a Novel Transient Receptor Potential Vanilloid Type 1 Modulator That Does Not Cause Hyperthermia in Rats

Sonya G. Lehto, Rami Tamir, Hong Deng et al. · Journal of Pharmacology and Experimental Therapeutics · 2008 · 160 citations